🇺🇸 FDA

Intelligence · Clinical Pipeline

George Institute for Pipeline

All ClinicalTrials.gov programs at George Institute for — phase, modality, and trial IDs.

Programs
83

Quick answer

George Institute for has 83 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

  1. -

    The George Institute

    Acute lower Respiratory Tract Infection or acute rhinosinusitis

    approved small molecule active

    1 trial

  2. ACETYLSALICYLIC ACID

    The George Institute

    Obstetrics – Preeclampsia

    approved small molecule active

    1 trial

  3. ALUTARD SQ epitel, injektionsvätska, suspension - 553 Hund, Livostin 0,5 mg/ml ögondroppar, suspension, Desloratadine Sandoz 5 mg filmdragerade tabletter, Nasonex 50 mikrogram/dos nässpray, suspension

    The George Institute

    Allergic rhinitis due to dog allergy

    approved small molecule active

    1 trial

  4. AMOXICILINA NORMON 1000 mg Comprimidos EFG

    The George Institute

    Infective endocarditis

    approved small molecule active

    1 trial

  5. ASS-ratiopharm® 100 mg TAH Tabletten, Xarelto 15 mg film-coated tablets

    The George Institute

    Risk of stroke by Atrial Fibrillation

    approved small molecule active

    1 trial

  6. Adrenalina B. Braun 1 mg/ml Solución Inyectable, Ropivacaína B. Braun 2 mg/ml solución inyectable y para perfusión EFG

    The George Institute

    Knee Osteoarthritis

    approved small molecule active

    1 trial

  7. Alirocumab, Placebo product for REGN727

    The George Institute

    Cardiac allograft vaculopathy in recent heart transplant recipients

    approved small molecule active

    1 trial

  8. Amiodarone hydrochloride 200 mg tablets

    The George Institute

    Persistent atrial fibrillation

    approved small molecule active

    1 trial

  9. Amoxicilina/Ácido clavulánico NORMON 1.000 mg/200 mg polvo para solución inyectable y para perfusión EFG, Amoxicilina/Ácido clavulánico NORMON 875 mg/125 mg comprimidos recubiertos con película EFG

    The George Institute

    Complicated acute appendicitis

    approved small molecule active

    1 trial

  10. BIMERVAX LP.8.1 emulsion for injection COVID-19 Vaccine (recombinant, adjuvanted), Spikevax bivalent Original/Omicron BA.1 25 micrograms/25 micrograms dispersion for injection COVID 19 mRNA Vaccine, Comirnaty 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, Spikevax 50 micrograms dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine, Comirnaty JN.1 30 micrograms/dose dispersion for injection in pre-filled syringe COVID-19 mRNA Vaccine, Nuvaxovid dispersion for injection COVI

    The George Institute

    COVID-19 infection

    approved small molecule active

    1 trial

  11. BUDESONIDE

    The George Institute

    Chronic obstructive pulmonary disease (COPD)

    approved small molecule active

    1 trial

  12. Betadine bucal 100 mg/ml solución bucal, Agua oxigenada Foret 3 % solución cutánea y concentrado para solución bucal, Agua para preparaciones inyectables Meinsol, disolvente para uso parenteral

    The George Institute

    Respiratory diseases

    approved small molecule active

    1 trial

  13. CARDIOPLEGIA SOLUTIONS

    The George Institute

    Cardiovascular pathology

    approved small molecule active

    1 trial

  14. CARVEDILOL, CARVEDILOL, FLECAINIDE

    The George Institute

    Idiopathic ventricular arrhythmias

    approved small molecule active

    1 trial

  15. CEFEPIME, TEICOPLANIN, METRONIDAZOLE, METRONIDAZOLE, MEROPENEM, TAZOBACTAM, VANCOMYCIN, LEVOFLOXACIN, CIPROFLOXACIN, CEFTAZIDIME, METRONIDAZOLE, CIPROFLOXACIN, LEVOFLOXACIN, AMIKACIN, CIPROFLOXACIN, PIPERACILLIN

    The George Institute

    Infectious diseases

    approved small molecule active

    1 trial

  16. CEFIXIME, CIPROFLOXACIN HYDROCHLORIDE, FOSFOMYCIN

    The George Institute

    Acute bacterial prostatitis

    approved small molecule active

    1 trial

  17. CELLULOSE, MICROCRYSTALLINE, COLLOIDAL SILICON DIOXIDE, CROSCARMELLOSE SODIUM, MAGNESIUM STEARATE, DARIDOREXANT

    The George Institute

    Patients with major depressive episode and moderate to severe insomnia disorder

    approved small molecule active

    1 trial

  18. CHORIOGONADOTROPIN ALFA , ESTRADIOL , PROGESTERONE

    The George Institute

    Infertility

    approved small molecule active

    1 trial

  19. CIPROFLOXACIN, CIPROFLOXACIN , CEFTRIAXONE , CEFTRIAXONE

    The George Institute

    Graft pyelonephritis in kidney transplant recipients

    approved small molecule active

    1 trial

  20. Clensia polvo para solución oral., CitraFleet Polvo para solución oral en sobre

    The George Institute

    colorectal cancer early detection

    approved small molecule active

    1 trial

  21. Comirnaty 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, Spikevax 0.2 mg/mL dispersion for injection COVID-19 mRNA Vaccine, EVUSHELD 150 mg + 150 mg solution for injection, Xevudy 500 mg concentrate for solution for infusion, Nuvaxovid dispersion for injection COVID-19 Vaccine (recombinant, adjuvanted)

    The George Institute

    Covid-19 infection

    approved small molecule active

    1 trial

  22. Cyclogest 400 mg óvulos

    The George Institute

    Infertility

    approved small molecule active

    1 trial

  23. DABIGATRAN ETEXILATE , CLOPIDOGREL , RIVAROXABAN , APIXABAN , ACENOCOUMAROL , EDOXABAN

    The George Institute

    patients who are requested a colonoscopy for any indication and are under antiplatelet treatment (except ASA) or anticoagulant treatment

    approved small molecule active

    1 trial

  24. DARBEPOETIN ALFA

    The George Institute

    hepatic trasplant

    approved small molecule active

    1 trial

  25. DOBUTAMINE , LEVOSIMENDAN

    The George Institute

    Heart failure patients with depressed left ventricular ejection fraction

    approved small molecule active

    1 trial

  26. Denominación Común Internacional (DCI): placebo (Suero fisiológico) Denominación Química: Cloruro Sódico 0.9% Forma molecular: NaCl Composición cuali y cuantitativa: 9mg/ml Forma farmacéutica: solución para pulverización nasal Dosis y vía de administración: 0.6ml/ día (6 pulverizaciones ) vía intranasa, Syntocinon 40 U.I./ml Solução para pulverização nasal

    The George Institute

    Borderline Personality Disorder.

    approved small molecule active

    1 trial

  27. Doxorubicin Accord 2 mg/ml koncentrat till infusionsvätska, lösning, Paclitaxel Accord 6 mg/ml koncentrat till infusionsvätska, lösning, Docetaxel Ebewe 10 mg/ml koncentrat till infusionsvätska, lösning, Epirubicin Accord 2 mg/ml injektions-/infusionsvätska, lösning, Sendoxan pulver till injektionsvätska, lösning

    The George Institute

    Breast cancer female NOS

    approved small molecule active

    1 trial

  28. ENDORET-PRGF

    The George Institute

    pterygium

    approved small molecule active

    1 trial

  29. ESTRIOL , ESTRADIOL HEMIHYDRATE, PROMESTRIENE, PROGESTERONE, ESTRADIOL VALERATE

    The George Institute

    Cervical cancer

    approved small molecule active

    1 trial

  30. Eliquis 5 mg film-coated tablets, Waran 2,5 mg tabletter, OPTISON 0.19 mg/ml dispersion for injection, SonoVue 8 microlitres/mL powder and solvent for dispersion for injection, Eliquis 2.5 mg film-coated tablets

    The George Institute

    Left ventricular thrombosis., Acute mycocardial infarction (AMI)

    approved small molecule active

    1 trial

  31. Elucirem 0.5 mmol/mL solution for injection, Gadovist 1.0 mmol/ml solution for injection in prefilled cartridge

    The George Institute

    Perianal fistula associated with Crohn's disease

    approved small molecule active

    1 trial

  32. Eufilina Venosa 200 mg solución inyectable, Clariscan 0,5 mmol/mL solución inyectable EFG, Rapiscan 400 microgram solution for injection

    The George Institute

    Coronary artery chronic total occlusion

    approved small molecule active

    1 trial

  33. FLUNARIZINE , TOPIRAMATE , AMITRIPTYLINE , PROPRANOLOL

    The George Institute

    Migraine

    approved small molecule active

    1 trial

  34. FOSFOMYCIN

    The George Institute

    Uncomplicated urinary tract infection (uUTI)

    approved small molecule active

    1 trial

  35. Ferinject 50 mg/ml dispersión inyectable y para perfusión

    The George Institute

    Acute coronary syndrome

    approved small molecule active

    1 trial

  36. Ferinject 50 mg/ml dispersión inyectable y para perfusión

    The George Institute

    Anemia in patients with chronic ischemia of the lower limb ischemia

    approved small molecule active

    1 trial

  37. Fluad Tetra, suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, adjuvanted), Zoonotic Influenza Vaccine Seqirus suspension for injection in pre-filled syringe Zoonotic influenza vaccine (H5N8) (surface antigen, inactivated, adjuvanted), Vaxigrip injektioneste, suspensio, esitäytetty ruisku. Kolmivalenttinen influenssarokote (virusfragmentit, inaktivoitu)., Fluad suspension for injection in pre-filled syringe Influenza vaccine (surface antigen, inactivated, adjuva

    The George Institute

    Avian influenza and seasonal influenza

    approved small molecule active

    1 trial

  38. Fludesoxiglucosa (18F)-Curium 185 MBq/ml, solución inyectable

    The George Institute

    Cardiovascular device infections

    approved small molecule active

    1 trial

  39. Fludex 1,5 mg, επικαλυμμένα με λεπτό υμένιο δισκία παρατεταμένης αποδέσμευσης., LUCIDEL 150 mg επικαλυμμένα με λεπτό υμένιο δισκία., Amlopen® 5mg καψάκια σκληρά, Inosamin 25mg, επικαλυμμένα με λεπτό υμένιο δισκία

    The George Institute

    Hypertension

    approved small molecule active

    1 trial

  40. Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)

    The George Institute

    Evaluation of the reduction of HPV infectivity and transmission before and after vaccination with 9vHPV

    approved small molecule active

    1 trial

  41. HUMAN SERUM ALBUMIN, SODIUM CHLORIDE

    The George Institute

    descompensated hepatic cirrosis

    approved small molecule active

    1 trial

  42. HYDROCORTISONE PH. EUR., HYDROCORTISONE PH. EUR.

    The George Institute

    Adrenal hyperplasia or isolated primary adrenal insufficiency or panhypopituitarism (secondary or tertiary adrenal insufficiency).

    approved small molecule active

    1 trial

  43. HYDROXYCHLOROQUINE , ABATACEPT , AZATHIOPRINE , SULFASALAZINE , METHOTREXATE , Cimzia 200 mg solution for injection in pre-filled syringe, LEFLUNOMIDE, RoActemra 162 mg solution for injection in pre-filled syringe., RoActemra 20 mg/mL concentrate for solution for infusion, PREDNISOLONE , Triamcinolone Hexacetonide 20 mg/ml suspension for injection, METHOTREXATE

    The George Institute

    Rheumatoid Arthritis

    approved small molecule active

    1 trial

  44. INDOCYANINE GREEN

    The George Institute

    Patients with liver tumors that will undergo minimally invasive liver surgery

    approved small molecule active

    1 trial

  45. INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN

    The George Institute

    Influenza, Immunity against influenza

    approved small molecule active

    1 trial

  46. Iomeron 400 mgI/ml solution for injection

    The George Institute

    Thoracic neoplasm

    approved small molecule active

    1 trial

  47. KENACORT 40 mg/ml sospensione iniettabile, Suero Fisiológico Braun 0,9% disolvente para uso parenteral Cloruro de sodio, Lidocaína B. Braun 20 mg/ml solución inyectable, BUPIVACAÍNA PHYSAN 0,25% SOLUCIÓN INYECTABLE

    The George Institute

    TRAPEZIUS MYOFASCIAL SYNDROME IN FIBROMYALGIA PATIENTS

    approved small molecule active

    1 trial

  48. LINEZOLID, LINEZOLID

    The George Institute

    Sepsis

    approved small molecule active

    1 trial

Frequently asked questions

How many pipeline programs does George Institute for have?

83 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.